Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-005355
Filing Date
2025-01-22
Accepted
2025-01-22 20:33:08
Documents
1
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm254168-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm254168-2_4seq1.xml 4 13235
  Complete submission text file 0001104659-25-005355.txt   14916
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Issuer) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O PLX PHARMA,INC.8285 EL RIO STREET SUITE 210 HOUSTON TX 77054
Business Address
Deliargyris Efthymios (Reporting) CIK: 0001751617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36792 | Film No.: 25547376